Cargando…
Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors
Angiotensin converting enzyme 2 (ACE2) downregulation is a key negative factor for the severity of lung edema and acute lung failure observed in patients infected with SARS-CoV-2. ACE2 downregulation affects the levels of diverse peptide mediators of the renin-agiotensin-aldestosterone and kallikrei...
Autores principales: | Rasaeifar, Bahareh, Gomez-Gutierrez, Patricia, Perez, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558388/ https://www.ncbi.nlm.nih.gov/pubmed/32967280 http://dx.doi.org/10.3390/ph13090259 |
Ejemplares similares
-
New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding
por: Rasaeifar, Bahareh, et al.
Publicado: (2020) -
In Vitro Pharmacological Profile of a New Small Molecule Bradykinin B(2) Receptor Antagonist
por: Lesage, Anne, et al.
Publicado: (2020) -
164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012) -
Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign
por: Gomez-Gutierrez, Patricia, et al.
Publicado: (2020) -
Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)